BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• News

  Alto Neuroscience Reports Topline Results from a Phase 2b Trial Evaluating ALTO-100 as a Treatment for Major Depressive Disorder

  October 22, 2024

   · 

  6 min read
• Press Releases

  Cothera Bioscience Announces FDA Fast Track Designation for Clinical Program PC-002

  October 22, 2024

   · 

  1 min read
• Press Releases

  Arbor Biotechnologies to Highlight New Preclinical Data Supporting Advancement of Pipeline Programs and Knock-In Applicability of Type V Nucleases at Upcoming Medical and Scientific Meetings

  October 22, 2024

   · 

  3 min read
• Business

  NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

  October 22, 2024

   · 

  1 min read
• Press Releases

  Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

  October 22, 2024

   · 

  5 min read
• Business

  Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

  October 22, 2024

   · 

  4 min read
• Business

  Ocuphire Pharma Announces Acquisition of Opus Genetics

  October 22, 2024

   · 

  11 min read
• Business

  Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

  October 22, 2024

   · 

  1 min read
• Business

  Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

  October 22, 2024

   · 

  6 min read
• Press Releases

  AbCellera to Present at Upcoming Investor Conferences in November 2024

  October 22, 2024

   · 

  1 min read